Stock Analysis

Kureha Third Quarter 2025 Earnings: EPS: JP¥47.71 (vs JP¥62.31 in 3Q 2024)

TSE:4023
Source: Shutterstock

Kureha (TSE:4023) Third Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥40.4b (down 9.0% from 3Q 2024).
  • Net income: JP¥2.45b (down 29% from 3Q 2024).
  • Profit margin: 6.1% (down from 7.8% in 3Q 2024).
  • EPS: JP¥47.71 (down from JP¥62.31 in 3Q 2024).
earnings-and-revenue-growth
TSE:4023 Earnings and Revenue Growth February 11th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kureha Earnings Insights

Looking ahead, revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan.

Performance of the Japanese Chemicals industry.

The company's shares are up 4.1% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Kureha, and understanding them should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if Kureha might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:4023

Kureha

Manufactures and sells functional materials, specialty chemicals, and plastics in Japan and internationally.

Excellent balance sheet average dividend payer.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.11% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|23.535% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor